Debunking the Delusion That Precision Oncology Is an Illusion
- PMID: 28550030
- PMCID: PMC5553950
- DOI: 10.1634/theoncologist.2017-0040
Debunking the Delusion That Precision Oncology Is an Illusion
Abstract
Many of the major advances in oncology over the past 2 decades are attributable to precision medicine, defined as biomarker‐driven treatment. Whether the results of precision medicine are real or an illusion is discussed here.
Conflict of interest statement
Disclosures of potential conflicts of interest may be found at the end of this article.
References
-
- Prasad V. Perspective: The precision‐oncology illusion. Nature 2016:537:S63. - PubMed
-
- Subbiah V, Kurzrock R. Universal genomic testing needed to win the war against cancer: Genomics is the diagnosis. JAMA Oncol 2016:2:719–720. - PubMed
-
- Le Tourneau C, Delord JP, Gonçalves A et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): A multicentre, open‐label, proof‐of‐concept, randomised, controlled phase 2 trial. Lancet Oncol 2015:16:1324–1334. - PubMed
-
- Wheler JJ, Janku F, Naing A et al. Cancer therapy directed by comprehensive genomic profiling: A single center study. Cancer Res 2016:76:3690–3701. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
